When discount cards might help alleviate the stress of large drug costs while in the temporary, they do not address the systemic issues driving up prescription rates from the U.S. Broader plan alterations could tackle the basis results in of mounting drug selling prices, for example deficiency of transparency in pricing and the role of intermediari